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Acute post-asphyxial encephalopathy occurring around the time of birth remains a major
cause of death and disability. The recent seminal insight that allows active neuroprotective
treatment is that even after profound asphyxia (the “primary” phase), many brain cells
show initial recovery from the insult during a short “latent” phase, typically lasting
approximately 6 h, only to die hours to days later after a “secondary” deterioration
characterized by seizures, cytotoxic edema, and progressive failure of cerebral oxidative
metabolism. Although many of these secondary processes are potentially injurious, they
appear to be primarily epiphenomena of the “execution” phase of cell death. Animal and
human studies designed around this conceptual framework have shown that moderate
cerebral hypothermia initiated as early as possible but before the onset of secondary
deterioration, and continued for a sufficient duration to allow the secondary deterioration
to resolve, has been associated with potent, long-lasting neuroprotection. Recent clinical
trials show that while therapeutic hypothermia significantly reduces morbidity and
mortality, many babies still die or survive with disabilities. The challenge for the future
is to find ways of improving the effectiveness of treatment. In this review, we will dissect
the known mechanisms of hypoxic-ischemic brain injury in relation to the known effects
of hypothermic neuroprotection.
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INTRODUCTION
Moderate to severe neonatal hypoxic-ischemic encephalopathy
occurs in approximately 1–3 cases per 1000 term live births in
developed nations (Kurinczuk et al., 2010), and remains a signifi-
cant cause of death and long-term neurodevelopmental disability
(Lawn et al., 2005; Marlow et al., 2005). The most devastating
complication in survivors is cerebral palsy, which is associated
with one of the very highest indices of burden of disease from
loss of potential productive members of society and direct bur-
dens on the individual, family, and social institutions that last the
entire life (Centers for Disease Control and Prevention (CDC),
2004). Approximately 15% of all cases of cerebral palsy are asso-
ciated with acute brain damage (encephalopathy) in term infants
(Mcintyre et al., 2011).
There is now compelling clinical evidence from meta-analyses
of large randomized controlled trials that prolonged moderate
cerebral hypothermia in term infants with moderate to severe
hypoxic-ischemic encephalopathy, started within a few hours
after birth and continued until resolution of the acute phase of
delayed cell death improves neurodevelopmental outcome in the
medium to long-term (Edwards et al., 2010; Guillet et al., 2012;
Shankaran et al., 2012b). This functional improvement is consis-
tent with reduced brain injury on modern imaging (Rutherford
et al., 2010; Shankaran et al., 2012a). Hypothermia suppresses
many potentially deleterious mechanisms, making it difficult to
distinguish between physiological changes during cooling that are
critically beneficial, compared with those that are either indiffer-
ent or even deleterious.
Current therapeutic hypothermia protocols are incompletely
neuroprotective, reducing the combined risk of death and severe
disability at 18 months of age by approximately 11% (Edwards
et al., 2010). Thus, many children continue to die, or survive
with moderate to severe handicap despite treatment with cur-
rent hypothermia protocols. Expanding our knowledge of the key
therapeutic targets of hypothermia could help to further improve
existing protection. In the present review we will critically assess
the potential mechanisms of hypothermic neuroprotection in
relation to the known window of opportunity for cooling after
severe hypoxia-ischemia (HI).
THE EVOLUTION OF HYPOXIC-ISCHEMIC INJURY
The central insight that underpinned development of therapeutic
hypothermia was that HI injury evolves over time, as illustrated
in Figure 1 (Gunn and Thoresen, 2006). We now know that
although some neurons likely die during the actual ischemic or
asphyxial event (the “primary” phase of injury, Figures 1, 2), the
hypoxia-induced impairment of cerebral oxidative metabolism,
cytotoxic edema, and accumulation of excitatory amino acids
(EAAs) typically recovers at least partially over approximately 30–
60min (Tan et al., 1996; Bennet et al., 2007b). This is followed
by a “latent” phase during which electroencephalogram (EEG)
activity remains suppressed but high energy phosphates are nor-
mal or near normal (Azzopardi et al., 1989; Gunn et al., 1997;
Bennet et al., 2006; Iwata et al., 2008). Notably, during this phase
there is post-asphyxial cerebral hypoperfusion associated with
reduced cerebral metabolism and improved tissue oxygenation in
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FIGURE 1 | The effects of 30min of cerebral ischemia (from t = 0,
shown by vertical dotted lines) with or without induced mild
hypothermia (shown by the bar) started 5.5 h after reperfusion in
near-term fetal sheep on fetal temperature, electroencephalographic
(EEG) intensity and cortical impedance (a measure of cell swelling).
The top panel shows changes in extradural (solid circles) and esophageal
(solid squares) temperature in the hypothermia group and extradural (open
circles) and esophageal (open squares) temperature in the normothermia
group. The lower two panels show changes in EEG intensity (dB) and
cortical impedance (expressed as percentage of baseline) in the
hypothermia (solid circles) and normothermia (open circles) groups. The
hypothermia group showed greater recovery of EEG intensity after
resolution of delayed seizures and complete suppression of the secondary
rise in impedance. Data modified from Gunn et al. (1998). ∗p < 0.05;
∗∗p < 0.001.
the near-term lamb (Jensen et al., 2006), consistent with active
suppression of cerebral metabolism.
With moderate to severe injury, this period is frequently fol-
lowed by progressive secondary deterioration many hours later
(from approximately 6–15 h), that is typically associated with
stereotypic seizures (Gunn et al., 1997), cytotoxic edema and
accumulation of excitotoxins, near-complete failure of cerebral
mitochondrial activity (Lorek et al., 1994; Bennet et al., 2006) and
eventual spreading cell death. More severe insults are typically
FIGURE 2 | Schematic diagram illustrating the different pathological
phases of cerebral injury after severe hypoxic-ischemia. OFRs, oxygen
free radicals; BBB, blood brain barrier; EAAs, excitatory amino acids; NO,
nitric oxide.
associated with evidence of greater primary damage (Williams
et al., 1992), and earlier and more severe secondary deteriora-
tion and neuronal loss (Williams et al., 1992; Lorek et al., 1994;
Sabir et al., 2012). In turn, the severity of secondary oxidative
metabolism derangement in newborns with birth asphyxia is
strongly associated with increased risk of mortality and adverse
neurodevelopmental outcome (Roth et al., 1992).
MECHANISMS OF INJURY DURING HYPOXIA-ISCHEMIA
Brain injury requires a period of insufficient delivery of oxy-
gen and substrates such as glucose (and lactate in the fetus)
such that neurons and glia cannot maintain homeostasis. Once
the neuron’s supply of high-energy metabolites such as adeno-
sine triphosphate (ATP) can no longer be maintained during
HI, the energy dependent mechanisms of intracellular homeosta-
sis including the Na+/K+ ATP dependent pump begin to fail.
Neuronal depolarization occurs, leading to sodium and calcium
entry into cells. This creates an osmotic and electrochemical gra-
dient that in turn favors further cation and water entry leading
to cell swelling (cytotoxic edema). Consequently, this may lead to
acute cell lysis when the homeostatic disturbance is sufficiently
severe (Rothman and Olney, 1995). Even after surprisingly pro-
longed and severe insults, however, many swollen neurons still
recover, at least temporarily, if the hypoxic insult is reversed or
the osmotic environment is manipulated. Evidence suggests that
several additional factors act to increase cell injury during and
following depolarization. One of these factors is the extracellular
accumulation of EAAs after neuronal depolarization coupled with
impaired energy dependent re-uptake, which promote further
receptor mediated cell swelling and intracellular calcium entry
(Rothman and Olney, 1995). Another factor is the generation
of oxygen free radicals such as the highly toxic hydroxyl radical
(OH), leading to lipid peroxidation and DNA/RNA fragmenta-
tion (Bagenholm et al., 1998; Fraser et al., 2008). Further, there is
compelling evidence that generation of the reactive oxygen species
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nitric oxide (NO) by neuronal nitric oxide synthase (nNOS) is
increased during and after HI, and that reaction of NO with
superoxide in the cytosol and mitochondria produces peroxyni-
trite and other reactive nitrogen species that are associated with
cell membrane, organelle and mitochondrial damage (Tan et al.,
1999). For example, selective nNOS blockade during asphyxia
reduced neuronal damage in the basal ganglia of preterm fetal
sheep (Drury et al., 2013). However, these factors largely appear
to be injurious only in the presence of hypoxic cell depolarization.
HYPOTHERMIA DURING HYPOXIA-ISCHEMIA
Hypothermia produces a reduction in cerebral metabolism of
approximately 5% for every 1 degree fall in temperature (Laptook
et al., 1995), which delays the onset of anoxic cell depolariza-
tion. The protective effects of hypothermia are not simply due
to reduced metabolism alone, however, since graded cooling sub-
stantially reduces damage for a given absolute duration of depo-
larization compared to normothermia (Bart et al., 1998). The
reduced accumulation of EAAs during intra-ischemic hypother-
mia (Nakashima and Todd, 1996a; Ooboshi et al., 2000), is
primarily due to delay in depolarization, although there is some
evidence for a reduction in the rate of release even after depolar-
ization has occurred (Nakashima and Todd, 1996b). In addition,
hypothermia potently suppresses NO and superoxide formation
in hippocampal slice cultures (Mcmanus et al., 2004), during
ischemia and reperfusion in rodents (Lei et al., 1997), cardiac
arrest in young adult dogs (Lei et al., 1994), and during and
immediately after HI in the piglet (Thoresen et al., 1997).
HYPOTHERMIA DURING REPERFUSION
Once blood flow and oxygenation are restored after acute HI,
there is a rapid burst of NO and superoxide formation (Thoresen
et al., 1997), and EAA levels rapidly fall in parallel with resolu-
tion of the acute cell swelling, typically over 30–60min (Tan et al.,
1996; Fraser et al., 2008). It would appear that this recovery can be
accelerated by cooling; hypothermia started immediately after HI
in newborn piglets was associated with reduced extracellular lev-
els of EAAs, and reduced NO efflux in the brain (Thoresen et al.,
1997).
HYPOTHERMIA AND THE BLOOD BRAIN BARRIER
Ischemic brain injury is generally associated withmarked opening
of the blood brain barrier (BBB) which may contribute to fur-
ther brain swelling. In adult rats, cooling after global ischemia was
associated with reduced BBB leakiness and brain edema 24 h later,
but only when induced within 1 h after ischemia (Preston and
Webster, 2004; Baumann et al., 2009). Such stabilization of the
BBB by hypothermia was associated with attenuated degradation
of key regulatory proteins in the vascular basement membrane
(Baumann et al., 2009). Similarly, hypothermia induced 1 h after
focal ischemia in rats was associated with improved BBB func-
tion, possibly by inhibiting metalloproteinase induction (Nagel
et al., 2008). However, the inhibition of metalloproteinases after
HI in neonatal rats has had inconsistent effects (Ranasinghe et al.,
2012). Given that treatment with hypothermia is highly neuro-
protective even when delayed by more than an hour after HI
(Gunn et al., 1997, 1998; Colbourne et al., 2000; Sabir et al., 2012),
it seems unlikely that this mechanism is a major contributor to
hypothermia’s beneficial effects.
CRITICAL CLUES FROM STUDIES OF HYPOTHERMIA DURING
THE LATENT PHASE
Although it remains unclear when exactly the brain becomes
irreversibly injured, there are consistent empirical data that the
so-called “latent” or early recovery phase of transient restora-
tion of cerebral oxidative metabolism, before onset of secondary
energy failure, represents the most realistic window of opportu-
nity for therapeutic intervention (Roelfsema et al., 2004; Gunn
and Gluckman, 2007). Thus, pragmatically, the window of inter-
vention appears to close indefinitely during secondary energy
failure, which corresponds either to overt cell death (Vannucci
et al., 2004), or to a critical “irreversible” stage in the evolution
of delayed cell death (Gunn and Gluckman, 2007).
For example, in the near-term fetal sheep, moderate hypother-
mia induced 90min after reperfusion from a severe episode of
cerebral ischemia (i.e., in the early latent phase) and continued
until 72 h after ischemia, prevented secondary cytotoxic edema,
improved electroencephalographic recovery, and reduced neu-
ronal and white matter injury (Gunn et al., 1997; Roelfsema et al.,
2004). However, only partial protection was seen in this paradigm
when hypothermia was delayed until just before the onset of sec-
ondary seizures (5.5 h after reperfusion, e.g. see Figure 1) (Gunn
et al., 1998; Roelfsema et al., 2004), and there was no signifi-
cant protection when the start of cooling was delayed until after
seizures were established (8.5 h after reperfusion) (Gunn et al.,
1999).
These observations are consistent with previous studies in
anaesthetized piglets subjected to severe HI, where application
of prolonged moderate to deep hypothermia for 24 h imme-
diately after resuscitation prevented secondary energy failure,
suppressed seizure burden, and reduced neural loss in the cor-
tex and basal ganglia (Edwards et al., 1995; Thoresen et al., 1995;
Tooley et al., 2003). Similar progressive loss of neuroprotection
was found when 5 h of moderate hypothermia was delayed for
up to 6 h after moderate HI in postnatal day 7 rat pups (Sabir
et al., 2012), while this relatively short period of hypothermia was
not protective at all after a more severe insult. Studies in adult
rodents strongly suggest that more prolonged cooling, for 48 h or
more, further improves the effect of delayed cooling (Colbourne
et al., 1999a); it remains unclear whether there would be further
benefit if cooling was continued for longer than approximately
48–72 h.
EVOLUTION OF INJURY DURING THE LATENT PHASE
The precise mechanism(s) which initiate the cascade leading to
delayed cell death after HI remain incompletely understood, but
are undoubtedly multi-factorial with excessive calcium influx,
pro- and anti-apoptotic proteins, and trophic factor withdrawal
during and after HI all playing a critical role (Zipfel et al., 2000;
Hagberg et al., 2009). For example, neural accumulation of cal-
cium precipitates continues for many hours after HI in the imma-
ture rodent (Stein and Vannucci, 1988), and is associated with
worsening structural morphology (Puka-Sundvall et al., 2000).
Although mitochondria can buffer increased levels of neuronal
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cytosolic calcium (Wang and Thayer, 1996), excessive seques-
tration of calcium by mitochondria may lead to inhibition of
the respiratory chain, uncoupling of oxidative phosphorylation
(Szydlowska and Tymianski, 2010), and permeabilization of the
mitochondrial membranes (the “intrinsic” apoptosis pathway).
In detail, HI results in activation of pro- and anti-apoptotic
proteins (Hagberg et al., 2009), and translocation of cytosolic
Bcl-2 associated × protein (Bax) to mitochondria (Rousset et al.,
2012), where it oligomerizes (with Bcl-2 family members Bak
and Bid) and creates non-specific protein pores in the outer
mitochondrial membrane. This allows leakage of pro-apoptotic
proteins and cytochrome c into the cytosol (Figure 3) (Hagberg
et al., 2009). Not only are pro- and anti-apoptotic proteins and
caspase-3 highly expressed in the immature brain (Polster et al.,
2003; Zhu et al., 2005; Soane et al., 2008), but regulating their
interaction can provide significant neuroprotection after perina-
tal HI (Gibson et al., 2001; Wang et al., 2010; Nijboer et al., 2011).
As the terminal electron acceptor of the mitochondrial electron
transport chain, loss of cytochrome c oxidase may be partic-
ularly decisive in the uncoupling of oxidative phosphorylation,
since it accounts for over 90% of cellular oxygen consump-
tion (Cooper and Springett, 1997). Thus, the permeabilization
of mitochondrial membranes, with detachment of soluble pro-
tein cytochrome c from cardiolipin on the inner mitochondrial
membrane (Hagberg et al., 2009), and release of apoptogenic fac-
tors including second mitochondria-derived activator of caspase
(Smac), direct inhibitor of apoptosis binding protein with low Pi
(Diablo) and apoptosis inducing factor (AIF) from themitochon-
drial intermembrane space (Martinou and Green, 2001), could
shift a potentially reversible injurious paradigm to irrevocable cell
death.
After its release cytosolic cytochrome c binds to apoptotic
protease-activating factor-1 (Apaf-1), and activates caspase 9 in
the presence of ATP or dATP to form an apoptosome, which
initiates the executioner caspase-3 (Martinou and Green, 2001),
and ultimately leads to DNA fragmentation (Figure 3). This func-
tional decline of mitochondria appears to be consistent with the
progressive fall in cytochrome oxidase seen from 3 h onwards after
asphyxia in fetal sheep (Bennet et al., 2010), before onset of sec-
ondary cytotoxic edema and stereotypic seizures. Critically, one
kinetic study using HeLa cell lines showed that, after initiation
of cytochrome c release, all cytochrome c was invariably released
from mitochondria within 5min, and this release preceded the
apoptotic cascade (Goldstein et al., 2000). There is good histolog-
ical evidence that programmed cell death is a significant contrib-
utor to post-hypoxic cell death in the developing human brain
(Edwards et al., 1997; Scott and Hegyi, 1997). Additional factors
that likely help trigger or augment programmed cell death include
loss of trophic support from astrocytic growth factors (Clawson
et al., 1999), and the inflammatory reaction to HI (Giulian and
Vaca, 1993), through activation of cell surface death receptors
(and thus the “extrinsic” apoptosis pathway; Graham et al., 2004).
The delayed increase in synthesis of down-stream mediators of
cell death such as NO and reactive oxygen species in this phase
are likely secondary to inflammation (Gehrmann et al., 1995). In
addition, recent data indicate that “extrinsic” TNF and Fas death
receptor engagement can also promote cross-over activation of
the “intrinsic” apoptotic pathway through association with the
pro-apoptotic tBid protein on Bak and Bax (Figure 3) (Wei et al.,
2001; Schug et al., 2011).
DOES HYPOTHERMIA SPECIFICALLY SUPPRESS DELAYED
PROGRAMMED CELL DEATH?
There is evidence that hypothermia may have a particular role
in suppressing the evolution of programmed cell death. Studies
using morphological criteria have had mixed outcomes. In the
piglet, hypothermia started after severe HI was reported to reduce
apoptotic cell death, but not necrotic cell death (Edwards et al.,
1995), with similar results reported after injury in rats (Xu et al.,
1998; Inamasu et al., 2000). However, in the adult rat, delayed
post-ischemic cell death prevented by hypothermia had a necrotic
appearance on detailed electron microscopic criteria (Colbourne
et al., 1999b), consistent with findings of amaturity related reduc-
tion in cytochrome c release, AIF and caspase-3 expression after
HI in rodents (Hu et al., 2000; Zhu et al., 2005).
It is important to appreciate that in practice these morpholog-
ical changes often do not closely reflect the underlying pathways
leading to cell death. By analogy with the active process of
developmental “pruning” of excess cells (including neurons), it
was originally suggested that an apoptotic morphology reflected
activation of “pre-programmed” cell death pathways (Beilharz
et al., 1995; Dell’anna et al., 1997). Although necrosis can reflect
immediate biophysical damage to the cell, such as membrane
instability or ion shifts leading to cell lysis in the primary phase
(Beilharz et al., 1995), there is now compelling evidence that
post-hypoxic cell death represents a continuum between apopto-
sis and necrosis, as recently reviewed (Northington et al., 2011).
In vitro, hypothermia during severe hypoxia reduced both “apop-
totic” and “necrotic” morphological cell death in developing
rat neurons, and suppressed hypoxia-associated protein synthe-
sis (Bossenmeyer-Pourie et al., 2000). Microarray analysis in
rats after focal ischemia confirmed that post-insult hypother-
mia suppressed gene responses to ischemia, particularly genes
involved in calcium homeostasis, cellular and synaptic integrity,
inflammation, cell death, and apoptosis (Nagel et al., 2012).
Although there are multiple pathways to programmed cell
death, as discussed above, caspase-3 is the final “executioner”
caspase, and thus caspase-3 activation may be used as a reason-
able marker of these pathways. Other in vitro studies have shown
that mild hypothermia suppressed H2O2-induced apoptosis and
caspase-3 induction in rat cortical neurons (Li et al., 2012), and
suppressed neuronal apoptosis induced by serum deprivation,
with significantly reduced activation of caspases -3, -8, and -
9 after 24 h, and reduced cytochrome c translocation consistent
with suppression of both the intrinsic and extrinsic pathways of
apoptosis (Xu et al., 2002). Further, hypothermia during focal
ischemia in adult rats reduced expression of the cell death recep-
tor Fas and activation of caspase-8, supporting a direct effect on
the extrinsic pathway of apoptosis (Liu et al., 2008).
These studies examined forms of intra-insult cooling.
However, there is supporting evidence from post-insult cooling
in vivo. For example, in the near-term fetal sheep, hypothermia
delayed for 90min after ischemia markedly suppressed caspase-3
activation in white matter (Roelfsema et al., 2004). Similarly, in
postnatal day 7 (P7) rats, an age when brain development is
comparable to the late preterm human infant (Rice et al., 1981),
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FIGURE 3 | Flow chart depicting several intracellular mechanisms
associated with permeabilization of the mitochondrial membranes,
leading to progressive failure of mitochondrial oxidative
phosphorylation and ultimately delayed programmed cell death.
Upstream triggers such as inflammation and trophic withdrawal activate
cell surface death receptors initiating the “extrinsic” pathway to
programmed cell death. Conversely, calcium overload and oxygen free
radicals appear to exert their effect predominantly at the mitochondrial
level via the “intrinsic” pathway. In addition, cross-over activation
between the “extrinsic” and “intrinsic” pathway may take place through
pro-apoptotic intermediates such as the BID protein. AIF, apoptosis
inducing factor. Apaf-1, apoptotic protease-activating factor−1; ATP,
adenosine triphosphate; BAK, Bcl2-antagonist/killer 1; BAX,
Bcl2-associated × protein; Bcl2, B-cell lymphoma 2 protein family; Bcl-XL,
B-cell lymphoma-extra-large; BID, BH3 interacting-domain death agonist;
Diablo, direct inhibitor of apoptosis binding protein with low Pi; P53, p53
tumor suppressor protein; Smac, Second mitochondria-derived activator of
caspase; tBID, truncated BH3 interacting-domain death agonist; TNF,
tumor necrosis factor receptor; TRAIL, TNF-related apoptosis-inducing
ligand receptor.
immediate induction of hypothermia after HI reduced caspase-
3 expression in the core area of cortical infarction but not in
the penumbra (Askalan et al., 2011), suggesting that hypother-
mia modulated both caspase-dependent and independent mech-
anisms. In the same paradigm, hypothermia also reduced caspase-
3 activation in pre-oligodendrocytes (Xiong et al., 2013). In
adult rats, mild hypothermia (33◦C) for 2 h after transient
endothelin-induced focal ischemia suppressed activated caspase-
3 immunoreactivity up to a week after the insult (Zgavc et al.,
2013). Similarly, hypothermic neuroprotection after transient
global ischemia in adult rats was associated with upregulation of
the anti-apoptotic protein bcl-2, and reduced expression of the
pro-apoptotic protein p53 (Zhang et al., 2010).
There is some evidence from adult models that hypothermia
can specifically suppress the mitochondrial permeability transi-
tion. For example, mild hypothermia either during or shortly
after transient focal ischemia attenuated the release of cytochrome
c (Yenari et al., 2002; Zhao et al., 2004). Similarly, protection of
the CA1 region of the hippocampus with mild hypothermia after
global ischemia was associated with reduced cytochrome c release
after 48 h, and with reduced caspase-3 and -9 activity at 12 and
24 h (Zhao et al., 2005). Further, neuroprotection with imme-
diate, prolonged cooling after cardiac arrest in adult minipigs
was associated with suppression of mitochondrial permeability
pore opening, leading to reduced release of cytochrome c and
other pro-apoptotic factors including AIF and reduced caspase-3
activation (Gong et al., 2013). Post-ischemic hypothermia main-
tained mitochondrial respiratory activity 2 h after reperfusion
in the adult gerbil (Canevari et al., 1999), and intra-ischemic
hypothermia has been shown to preserve activity for 4 days after
a similar insult in neonatal rats (Nakai et al., 2001). Presently,
there are no data evaluating mitochondrial function in vivo dur-
ing therapeutic hypothermia following HI in the developing
brain. However, hypothermia after cardiac arrest in adult minip-
igs substantially improved recovery of mitochondrial membrane
potential and respiration (Gong et al., 2013).
Finally, there is evidence that combined treatment with the
anti-apoptotic agent, insulin-like growth factor 1 (Guan et al.,
2001), and hypothermia starting 4.5 h after cerebral ischemia
in near-term fetal sheep did not show additive neuroprotection
(George et al., 2011). This observation suggests that their mech-
anisms of action overlap. Taken as a whole, these studies indicate
that hypothermia can suppress apoptosis, likely through several
pathways including reduction of mitochondrial permeability (the
intrinsic pathway) and reduced activation of the extrinsic pathway
of apoptosis.
HYPOTHERMIA AND INFLAMMATORY SECOND MESSENGERS
Brain injury leads to induction of the inflammatory cascade with
increased release of cytokines and interleukins (IL) (Hagberg
www.frontiersin.org February 2014 | Volume 8 | Article 40 | 5
Wassink et al. Hypothermia and HIE
et al., 2012). These compounds are believed to exacerbate delayed
injury, whether by direct neurotoxicity and induction of apopto-
sis or by promoting leukocyte diapedesis into the ischemic brain.
Experimentally, cooling potently suppresses this inflammatory
reaction (Roelfsema et al., 2004). For example, in vitro, hypother-
mia inhibits microglia proliferation, chemotaxis, induction of
pro-inflammatory cytokines, and attenuates microglia neuro-
toxicity, during and critically, after exposure to both hypoxia
and lipopolysaccharide (Si et al., 1997; Schmitt et al., 2007; Seo
et al., 2012). Further, hypothermia can suppress translocation and
binding of nuclear factor kappa-B, a key inflammatory transcrip-
tion factor that is activated after cerebral ischemia (Yenari and
Han, 2006). In addition, there is limited evidence that cooling
microglia after activation with lipopolysaccharide increases pro-
duction of anti-inflammatory cytokines in culture (Diestel et al.,
2010).
Consistent with these in vitro findings, hypothermia in adult
rats after transient focal ischemia reduced delayed increases in
interleukin-1β (IL-1β) and tumor necrosis factor alpha (TNF-α)
but not transforming growth factor beta (TGF-ß) in the stria-
tum (Ceulemans et al., 2011). In adult pigs, immediate mild
cooling after brief cardiac arrest was associated with attenua-
tion of IL-1β, TNF-α, intercellular adhesion molecule-1 mRNA,
and interleukin-1 (IL-1) protein induction 24 h after resuscitation
(Meybohm et al., 2010). Similarly, post-insult hypothermia has
been associated with consistent suppression of activatedmicroglia
after transient ischemia or asphyxia in fetal sheep (Roelfsema
et al., 2004; Bennet et al., 2007c; Barrett et al., 2012; George
et al., 2012). This broad reduction in inflammatory signaling may
offer significant mitochondrial protection. For example, cytokine
mediated iNOS expression increases NO levels, which compete
with molecular oxygen at its binding site on cytochrome oxi-
dase (Brown, 1997), potently suppressing oxidative metabolism
and thus reducing ATP levels (Tatsumi et al., 2000). Furthermore,
TNF-α and interferon-γ mediated iNOS expression were associ-
ated with mitochondrial DNA damage and apoptosis in cultured
oligodendrocytes (Druzhyna et al., 2005).
Intriguingly, despite the potent suppression of microglia by
hypothermia, it has little effect on astrocytic proliferation in
vitro (Si et al., 1997). This raises the possibility that hypother-
mic protection against post-ischemic neuronal damage may be,
in part, the result of differential effects on glia, with suppres-
sion of microglial activation but relative sparing of potentially
pro-survival astrocytic reactions.
HYPOTHERMIA AND EXCITOTOXICITY
In contrast to their role during the primary and reperfusion
phases, the importance of excitotoxins after reperfusion remains
surprisingly unclear, given that extracellular levels rapidly return
to baseline values (Tan et al., 1996; Thoresen et al., 1997). The
apparent protection seen in early studies of anti-excitotoxic agents
is difficult to interpret as these studies did not control for cere-
bral temperature (Mcdonald et al., 1987; Hattori et al., 1989).
Indeed, subsequent studies suggested that the effects of glutamate
blockade during HI were either largely or synergistically mediated
through drug-induced hypothermia (Ikonomidou et al., 1989;
Engidawork et al., 2001). In an elegant study in the adult rat,
Nurse and Corbett showed that the apparent neuroprotective
effect of NBQX, a glutamate antagonist administered from
1 h after mild cerebral ischemia, was directly associated with
mild endogenous hypothermia for several days that developed
an hour after drug administration (Nurse and Corbett, 1996).
Strikingly, similar neuroprotection was induced by application of
the same hypothermia profile over 28 h, while conversely NBQX
“neuroprotection” was abolished by maintaining normothermia.
Furthermore, anti-excitotoxin therapy limited to the secondary
phase did not reduce neuronal injury in the severely injured
parasagittal cortex of fetal sheep, and had only limited neuropro-
tective effects in more mildly affected areas of the brain (Tan et al.,
1992; Gressens et al., 2011).
Nevertheless, even with normal levels of extracellular glu-
tamate, excitotoxicity may still play an indirect injurious role.
Pathological hyperexcitability of glutamate receptors has been
reported in P10 rats for many hours after HI, with improved
neuronal outcome after receptor blockade (Jensen et al., 1998).
Further, neuronal death after ischemia has been associated with a
selective, delayed change in the composition of the alpha-amino-
3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) receptor,
with specific down-regulation of GluR2, the subunit that lim-
its Ca2+ influx through the AMPA receptor. This may facilitate
further excessive influx of Ca2+ during spontaneous glutamin-
ergic activity after HI, thus promoting programmed cell death.
In adult gerbils, delayed hypothermia from 20min after global
ischemia attenuated these changes in the GluR2 subunit, pro-
viding an additional possible mechanism for indirect protection
from excessive excitation (Colbourne et al., 2003).
Supporting this hypothesis, despite suppression of overall
EEG activity for many hours after asphyxia, transient epilepti-
form activity was seen in the early recovery phase in preterm
sheep fetuses that developed severe injury (George et al., 2004),
and was correlated with the severity of neuronal loss in the
striatum and hippocampus (Dean et al., 2006b; Bennet et al.,
2007c). Suppression of these EEG transients with a glutamate
receptor antagonist partially reduced cell loss (Dean et al.,
2006a). Furthermore, neuroprotection with post-asphyxial mod-
erate cerebral hypothermia in the preterm fetal sheep was asso-
ciated with a marked reduction in numbers of epileptiform
transients in the first 6 h after asphyxia, and reduced ampli-
tude but not numbers of delayed seizures (Bennet et al., 2007a).
The combination of glutamate receptor antagonist infusion and
hypothermia after severe asphyxia in preterm fetal sheep, how-
ever, showed non-additive neuroprotection, consistent with the
suggestion that therapeutic hypothermia is partly protective by
attenuating this receptor hyperactivity (George et al., 2012).
Further studies are needed to determine whether this is also the
case after hypoxic-ischemic injury in the term-equivalent brain.
HYPOTHERMIA AND INDUCTION OF GROWTH FACTORS
Contrary to the assumption that hypothermia generally sup-
presses new protein synthesis, there is evidence in the adult
rat that mild hypothermia after cardiac arrest or ischemia
is associated with augmentation of growth factors such as
brain-derived neurotrophic factor (BDNF), glial-cell-line derived
neurotrophic factor and extracellular-signal regulated kinase
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(D’Cruz et al., 2002; Schmidt et al., 2003; Kim et al., 2011), which
might help protect injured cells. However, BDNF infusions dur-
ing cardiac arrest in normothermic rats were not neuroprotective
(Callaway et al., 2008). Thus, induction of these growth factors
alone does not seem to explain the protective effects of mild
hypothermia after resuscitation.
HYPOTHERMIA DURING THE SECONDARY PHASE
Mitochondrial failure is a hallmark of secondary injury evolu-
tion (Bennet et al., 2006). Thus, maintaining mitochondria intact
after severe HI is crucial in promoting neuroprotection. There is
compelling evidence that hypothermia started in the latent phase
must be continued for 48 h or more to maintain improved recov-
ery of mitochondrial membrane potential and respiration (Gong
et al., 2013), and prevent cell death (Gunn and Thoresen, 2006).
The precise reasons are unknown. The most likely explanation
is that it is necessary to continue suppressing the programmed
cell death and inflammatory pathways until normal homeostasis
returns. Alternatively, it could in part reflect suppression of sec-
ondary events in this phase, including hyperperfusion, cytotoxic
edema and delayed seizures. For example, selective head or whole
body cooling in newborn piglets failed to provide any protection
when delayed until 3 h after the insult and continued for only 24 h
(Karlsson et al., 2008).
In the near-term fetal sheep, cerebral hypothermia started
5.5 h after ischemia and continued until 72 h, was associated
with marked extension of secondary hypoperfusion, to nearly
24 h after the insult (Gunn et al., 1998). We have previously
shown that this hypoperfusion phase is associated with sup-
pressed cerebral metabolism in the preterm fetal sheep (Jensen
et al., 2006). Although prolonged cerebral hypoperfusion after
asphyxia neonatorum has been associated with adverse clinical
outcome (Elstad et al., 2011), the prolongation of reduced blood
flow from cooling was associated with improved neural outcome
(Gunn et al., 1998). Conversely, the subsequent onset of sec-
ondary hyperperfusion is strongly associated with injury, both in
fetal sheep (Bennet et al., 2006), and in newborn infants (Elstad
et al., 2011). However, cooling in the fetal sheep prevents hyper-
perfusion, independently of subsequent neuroprotection (Gunn
et al., 1997, 1998).
Similarly, neuroprotection with cerebral cooling started
90min after cerebral ischemia was associated with potent pre-
vention of secondary cytotoxic edema in near-term fetal sheep
(Gunn et al., 1997). Intriguingly, hypothermia started after the
onset of secondary seizures (8.5 h after ischemia) also completely
prevented secondary cytotoxic edema in the same paradigm,
but offered no significant neuroprotection (Gunn et al., 1999).
In vitro, cooling can prevent intracellular ion and water entry
and the consequent osmotic cell swelling even if the ATP
dependent Na+/K+ pump is inhibited by ouabain (Zeevalk
and Nicklas, 1996). These findings suggest that suppression
of cell swelling is not a direct mechanism of hypothermic
neuroprotection.
Clinical studies have found a reduced seizure burden dur-
ing cooling of infants with hypoxic-ischemic encephalopathy
(Glass et al., 2011; Srinivasakumar et al., 2013). Interestingly,
despite the effects on cerebral metabolism and perfusion, and
the reduction in neuronal loss, post-insult hypothermia did
not significantly reduce the rate of electrographic seizures after
ischemia or asphyxia in fetal sheep, but did reduce their ampli-
tude (Gunn et al., 1998; Bennet et al., 2007a). Assuming that
coupling of flow-metabolism remains intact, the reduced carotid
blood flow suggests that cooling may have ameliorated the exces-
sive local metabolic demand associated with seizure activity,
which has been shown to directly mediate local neuronal death
(Ingvar, 1986; Pereira De Vasconcelos et al., 2002). Treatment
with MK-801, a highly potent, selective glutamate antagonist,
between 6 and 24 h after cerebral ischemia prevented delayed
post-ischemic seizures and completely suppressed fetal EEG activ-
ity (Tan et al., 1992). Surprisingly, there was no improvement
in parasagittal neuronal loss, and only a modest improvement
in less damaged regions such as the temporal lobe (Tan et al.,
1992). These findings suggest that severe seizure activity in the
secondary phase may contribute to spreading of injury from
the core area of damage to more mildly affected regions, and
thus anticonvulsant therapy during hypothermia might modu-
late outcome, although it would be unlikely to alleviate major
disabilities.
CLINICAL IMPLICATIONS?
Collectively, the experimental findings described in this review
strongly indicate that to achieve optimal neuroprotection, thera-
peutic hypothermia should be initiated as soon as possible after
resuscitation, within approximately the first 6 h of life, should
involve cooling by approximately 3–5◦C, and should be contin-
ued for approximately 48–72 h until resolution of the secondary
phase of injury. Given that in clinical trials to date infants cool-
ing was not started until typically 4.5–5 h (Edwards et al., 2010),
it is extremely likely that a pragmatic focus on starting cool-
ing earlier would substantially improve the outcomes of current
clinical protocols for therapeutic hypothermia (Thoresen et al.,
2013).
Beyond this, further advances are likely to come from devel-
oping complementary therapies to add to cooling. As out-
lined in this review, the protective mechanisms that under-
lie therapeutic hypothermia are multifactorial. Suppression of
inflammation, intracellular signaling and programmed cell death
are all important potential pathways to neuroprotection after
induced hypothermia. Strategies to augment hypothermic pro-
tection may involve protecting mitochondrial function during
the latent phase, for example with the natural hormone mela-
tonin (Robertson et al., 2012). Alternatively it may be pos-
sible to actively augment neural recovery during long-term
recovery after treatment with hypothermia, for example with
cell therapy as suggested by preclinical models (Bennet et al.,
2012).
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